Cancer specialist from Iraq awarded prestigious UK government scholarship
A talented young clinical cancer specialist from Iraq, Dr Mohammed Saleem Mohammed, has been awarded a prestigious Chevening scholarship to study oncology at the University of Hull.
Chevening scholarships are the UK government’s global scholarship scheme, funded by the Foreign and Commonwealth Office and partner universities. Chevening scholars, like Dr Mohammed, are chosen for their ambition, drive and leadership potential, their commitment to organisational development, and their talent for innovation and creativity.
In Iraq, through collaborations will fellow clinical oncologists, Dr Mohammed succeeded in establishing a reputable cancer care centre, which spurred authorities to fund and build a cancer hospital with advanced diagnostic and treatment facilities.
With a significant lack of available training in translational and molecular oncology in Iraq, Dr Mohammed has joined the University as a student on the MSc Translational Oncology, which upon completion will allow him to venture further into academic oncology and cancer research.
His time at the University will form an impression that will positively influence his future career once he returns home next year. Ultimately, he will promote the training of other cancer care medics, as well as help establish a cancer research centre.
Of the MSc programme, Dr Mohammed said: “I have found the course to be both enjoyable and insightful. I have learnt a lot, and this has helped fill many of the clinical gaps I had; it has explained why not all patients respond to therapy. I would personally recommended this course to any medical oncologist, as it addresses the molecular basis of cancer, which helps us tailor our therapy to our patients”.
Dr Stephen Maher, the MSc programme coordinator, said: “We are delighted to have Dr Mohammed on the course, which is now in its second year. A primary goal of the programme is to further educate high quality clinicians and scientists who will go on to be leaders in oncology, helping make things better for cancer patients everywhere.”